Overall rank by patents
#6,478
of 50,000 tracked assignees
USPTO PatentsView assignee record - 52 granted patents across 40 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).
The verdict
According to USPTO PatentsView, Sartorius ranks #6,478 of 50,000 tracked US assignees by granted-patent volume, with 52 patents across 40 technology areas.
USPTO PatentsView assignee plate
Corpus R6478 · US Corporation #6,478 · 52 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Sharp Life Science (eu) Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Seco Tools AB · near
55 score
HAI Robotics · near
55 score
Sartorius Stedim Nor… · this assignee
55 score
Cenovus Energy · near
55 score
Kraton Polymers · near
55 score
3D Lighting Innovati… · lowest
7 score
What this shows Sartorius Stedim North America Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-WIDE, INNOV-PAR, CLAIMS-RICH, TYPE-USCORP, VEL-SURGE, BOOK-FULL. Volume places it #6,478 of 50,000; Innovation Score 54.8/100 sits in the top 7% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Sharp Life Science (eu) Limited (±0 grants).
Sartorius Stedim North America Inc. has been granted 52 US utility patents between 2015 and 2025, placing Sartorius Stedim North America Inc. at #6,478 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 40 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a US Corporation, Sartorius Stedim North America Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Sartorius sits between Shenzhen Neewer Technology Co. Ltd (52 patents, rank #6,481) and Technology Research Association FOR Future Additive Manufacturing (52 patents, rank #6,489) - the closest US assignees by grant volume. The composite Innovation Score of 54.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 30 grants, compared with 16 in the 2015–2019 window, a +88% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Sartorius Stedim North America Inc.'s 17.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 40 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SHENZHEN NEEWER TECHNOLOGY CO. LTD
52 patents
SHOP VAC CORPORATION
52 patents
SIERRA WIRELESS, INC.
52 patents
SOREMARTEC S.A.
52 patents
Sharp Life Science (EU) Limited
52 patents
Sun Hydraulics, LLC
52 patents
Sutro Biopharma, Inc.
52 patents
TECHNOLOGY RESEARCH ASSOCIATION FOR FUTURE ADDITIVE MANUFACTURING
52 patents
Sartorius Stedim North America Inc.
52 patents
What this shows Sartorius holds 52 patents at rank #6,485, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,485 in granted patent volume.
Other assignees with the most granted patents in Sartorius's primary technology class.
Two PlainPatent-derived peer sets for Sartorius, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (55 here).
Nearest assignees by average claims per patent (17.9 here).
Sartorius's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
55 Top 7% higher than 93% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 1.9% |
| 2016 | 2 | 3.8% |
| 2017 | 1 | 1.9% |
| 2018 | 9 | 17.3% |
| 2019 | 3 | 5.8% |
| 2020 | 4 | 7.7% |
| 2021 | 8 | 15.4% |
| 2022 | 7 | 13.5% |
| 2023 | 7 | 13.5% |
| 2024 | 4 | 7.7% |
| 2025partial year | 6 | 11.5% |
Top 15 of 40 technology areas
Overall rank by patents
#6,478
of 50,000 tracked assignees
54.8 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.